针对抗脂综合征患者的非药物康复干预:一个范围审查
Alexandra E Harper1,2, Yen T Chen3, Stephanie Tancer3
1Department of Physical Medicine and Rehabilitation, University of Michigan, Ann Arbor, MI, USA.
Lupus
|December 19, 2023
概括
对于抗脂综合征 (APS) 的非药理干预方法存在有限的研究. 未来的研究应该探索运动和其他疗法来管理非血栓性症状并改善患者的治疗结果.
科学领域:
- 类风湿病学 类风湿病学
- 临床医学 临床医学
- 康复科学 康复科学 康复科学
背景情况:
- 抗脂综合征 (APS) 是一种与血栓形成和产科并发症相关的自身免疫性疾病.
- 目前的治疗主要侧重于抗凝药,可能导致非血栓性症状的治疗不够.
- 患者报告的需求凸显了对生活方式干预措施 (如体育活动) 的指导的渴望.
研究的目的:
- 系统地审查针对被诊断患有抗脂综合征 (APS) 的个人进行的现有非药物干预研究.
- 确定研究缺口,并探索超越药物治疗的潜在治疗途径,用于APS管理.
主要方法:
- 从1983年到2023年2月,对多个数据库 (PubMed,Embase,Scopus,Web of Science,CINAHL,ClinicalTrials.gov) 进行了全面的范围审查.
- 包括专注于非药物干预的研究,使用患者报告的APS患者的结果指标.
- 仅报告生理结果的研究被排除在外,以专注于患者体验.
主要成果:
- 审查中只发现了一项案例研究,研究了一项运动计划的安全性和有效性,该研究对一名患有二次APS的年轻男性进行.
- 尽管缺乏直接证据,但患者反表明在APS管理中对体力活动和炼指导的需求.
- 用于治疗狼的几种非药物干预措施被确定为潜在的相关,狼是一种经常与APS并发症的疾病.
结论:
- 非药物干预措施对管理非血栓性APS症状,包括神经,身体和认知问题,而不是通过抗凝药完全解决的治疗有希望.
- 严格的研究对于确定这些干预措施的安全性和有效性至关重要,特别是运动,考虑到APS特定的风险.
- 建议采用涉及康复专业人员的多学科方法来开发和测试新型干预措施,以改善APS患者的健康结果并满足未满足的患者需求.
相关概念视频
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
708
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
708
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
187
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
187
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
526
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
526
01:29Inflammatory Bowel Disease IV: Pharmacological Management
129
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
129
01:29Chronic Pancreatitis II: Collaborative Care
92
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
92